Applied Therapeutics faces a class-action lawsuit alleging misleading information about its govorestat clinical trials. The FDA issued a Complete Response Letter rejecting the drug’s application and a warning letter citing data capture and dosing errors. The company’s stock plummeted, and leadership changes were announced. An analyst downgraded the stock, reflecting significant market concerns.
Walgreens Boots Alliance has agreed to pay $100 million to settle a class action lawsuit alleging deceptive pricing practices within its Prescription Savings Club program. The plaintiffs claimed Walgreens inflated prices for generic drugs to insurers while offering lower prices to cash-paying customers, resulting in overpayments for insured individuals. The settlement comes as Walgreens faces scrutiny over its pricing practices and its impact on healthcare costs.
Faruqi & Faruqi, LLP, a prominent national securities law firm, is conducting an investigation into potential securities law violations by AMMO, Inc. Investors who suffered losses exceeding $50,000 in AMMO between August 19, 2020 and September 24, 2024 are encouraged to contact the firm to discuss their legal options.
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Acadia Healthcare Company, Inc. (ACHC) and encourages investors who suffered losses exceeding $100,000 between February 28, 2020, and October 18, 2024, to contact the firm. The investigation focuses on allegations that Acadia Healthcare misled investors about its business practices, including allegations of patient abuse and deceptive billing practices. Investors who believe they may have been affected are encouraged to contact Faruqi & Faruqi partner Josh Wilson directly.
Alibaba Group has agreed to pay $433.5 million to settle a class-action lawsuit accusing the company of misleading investors about its exclusivity practices. The lawsuit alleged that Alibaba’s actions artificially inflated its stock price, leading to financial losses for investors. The company denies wrongdoing but settled to avoid further litigation costs.
Weedmaps, the popular cannabis marketplace platform, is facing a class action lawsuit alleging it misled investors about its performance metrics. The lawsuit follows an SEC settlement where Weedmaps and former executives were fined for inflating user numbers. The company is also battling a stock price decline, risking delisting from NASDAQ.
Robbins Geller Rudman & Dowd LLP is representing investors who purchased Edwards Lifesciences Corporation (EW) securities between February 6, 2024 and July 24, 2024, in a class action lawsuit alleging that the company made false and misleading statements about its financial performance and prospects. The lawsuit claims that Edwards Lifesciences misrepresented the growth potential of its Transcatheter Aortic Valve Replacement (TAVR) product, leading to a significant stock price drop after the company announced disappointing second-quarter 2024 results. Investors who suffered losses during this period have until December 13, 2024, to seek appointment as lead plaintiff in the lawsuit.
Faruqi & Faruqi, LLP, a leading securities law firm, is investigating potential claims against iLearningEngines, Inc. after Hindenburg Research alleged the company inflated its revenue through undisclosed related party transactions. Investors who suffered losses exceeding $75,000 are encouraged to contact the firm to discuss their legal options.
Faruqi & Faruqi, LLP, a leading securities law firm, is investigating potential claims against Spire Global, Inc. (SPIR) for alleged misstatements about its revenue recognition practices. The firm encourages investors who suffered losses exceeding $75,000 to contact them.
Faruqi & Faruqi, LLP, a national securities law firm, is investigating potential claims against PDD Holdings Inc. (formerly known as Pinduoduo Inc.) for alleged securities fraud. The firm is seeking investors who lost over $100,000 in PDD between April 30, 2021, and June 25, 2024, to join a class action lawsuit. The lawsuit alleges that PDD misled investors about its business practices, including the presence of malware in its apps and the sale of products made by forced labor.
